Patent · US Active

Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens

US8236324B2 · kind B2 · utility

2Cited by

8References

11Claims

0Family size

Assignee

INSTITUT PASTEUR · FR

Inventors

Pierre Charneau · Paris, FR
Francois Clavel · Rockville, US
Andrew Borman · Vernouillet, FR
Caroline Quillent · Vitry-sur-Seine, FR
Denise Guetard · Paris, FR
Luc Montagnier · Le Plessis-Robinson, FR
Jacqueline Donjon De Saint-Martin · Clamart, FR
Jacques H.M. Cohen · Reims, FR

Key dates

Filing date	Nov 2, 2006
Grant date	Aug 7, 2012
Priority date	—
Expiry date	Apr 16, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/975
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

An HIV-1 type (or subtype) O retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognized by antibodies isolated from a serum resulting from infection by an HIV-1 type O VAU strain or an HIV-1 type (or subtype) O DUR strain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.